Infection and Drug Resistance
Volume 15, 2022 - Issue
ORIGINAL RESEARCH
More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia
Atalay Goshu Muluneh1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence[email protected]
https://orcid.org/0000-0002-2556-4158View further author information
https://orcid.org/0000-0002-2556-4158View further author information, , Kassahun Alemu Gelaye1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopiahttps://orcid.org/0000-0003-4647-5178View further author information
https://orcid.org/0000-0003-4647-5178View further author information, , , , , Mulugeta Ayalew Yimer3 Department of Pediatrics and Child health, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopiahttps://orcid.org/0000-0003-3089-2567View further author information
https://orcid.org/0000-0003-3089-2567View further author information & Getahun Molla Kassa1 Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopiahttps://orcid.org/0000-0002-9926-7797View further author information
https://orcid.org/0000-0002-9926-7797View further author information show all